Lorcaserin/Phentermine

绿卡色林/芬特明

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLorcaserin/Phentermine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors agonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsBeta adrenergic receptorsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Lorcaserin Hydrochloride HemihydratePhentermine
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesArena Pharmaceuticals IncEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArena Pharmaceuticals IncEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A